|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||
| NET INCOME | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Allowance for credit losses | |||||
| Allowance for inventory obsolescence | |||||
| Stock-based compensation | |||||
| Amortization of deferred finance costs | |||||
| Amortization of deferred financing costs | |||||
| Write-off of deferred financing costs | |||||
| Amortization of inventory step-up | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable - trade | |||||
| Inventories | |||||
| Deferred taxes | |||||
| Prepaid expense and other assets | |||||
| Right of use asset | |||||
| Right-of-use asset | |||||
| Accounts payable | |||||
| Income taxes payable | |||||
| Lease liability | |||||
| Accrued liabilities and other liabilities | |||||
| Accrued expense and other current liabilities | |||||
| Product returns | |||||
| Net cash provided by operating activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||||
| Cash paid for Irwin acquisition | |||||
| Purchase of property and equipment | |||||
| Net cash used in investing activities | |||||
| Mimi’s Rock Corp | |||||
| Assets of MusclePharm Corporation | |||||
| Total net cash used in investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||
| Proceeds from exercise of stock options | |||||
| Repurchases of common stock | |||||
| Borrowings on term loans | |||||
| Payments on term loans | |||||
| 2025 Term Loan | |||||
| The 2023 Term Loan | |||||
| Total payments on term loans | |||||
| Payoff of 2023 term loans | |||||
| Borrowings on line of credit | |||||
| Net cash provided by (used in) financing activities | |||||
| Foreign currency impact on cash | |||||
| Foreign currency impact on cash | |||||
| CHANGE IN CASH AND RESTRICTED CASH | |||||
| CASH AND RESTRICTED CASH, BEGINNING OF PERIOD | |||||
| CASH AND CASH EQUIVALENTS, END OF PERIOD | |||||
| Supplemental cash flow disclosure | |||||
| Cash paid for income taxes | |||||
| Cash paid for interest, net of amounts capitalized | |||||
| Non-cash investing and financing activities | |||||
| Addition to right-of-use assets from new operating lease liabilities | |||||
Loading...